Gilead Sciences Inc (NASDAQ:GILD) on 02/04/2019 declared a dividend of $ 0.6300 per share payable on March 28, 2019 to shareholders of record as of March 15, 2019. Dividend amount recorded is an increase of $ 0.06 from last dividend Paid.

Gilead Sciences Inc (NASDAQ:GILD) has paid dividends since 2015, has a current dividend yield of 3.5974302292% and has increased its dividends for 3 successive years.

Gilead Sciences Inc's market cap is $ 90,618,081,000 and has a PE ratio of 56.95. The stock price closed yesterday at $ 70.05 and has a 52 week low/high of $ 60.32 and $ 84.58.

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary area of focuses include HIV/AIDS, liver diseases, hematology/oncology and inflammation/respiratory diseases. Co.'s portfolio of marketed products includes AmBisome®, Atripla®, Biktarvy®, Cayston®, Complera®/Eviplera®, Descovy®, Emtriva®, Epclusa®, Genvoya®, Harvoni®, Hepsera®, Letairis®, Odefsey®, Ranexa®, Sovaldi®, Stribild®, Truvada®, Tybost®, Vemlidy®, Viread®, Vosevi®, YescartaTM and Zydelig®.

For more information on Gilead Sciences Inc click here.